Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Sarcoma
×
Ipilimumab
×
Clear all
Filters
3
NCT03058289
2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2
Completed
111 enrolled
21 charts
NCT03752398
2024-07-05
DUET-3
Xencor, Inc.
Phase 1
Completed
198 enrolled
NCT04480502
2024-05-17
ENVASARC
Tracon Pharmaceuticals Inc.
Phase 2
Active not recruiting
207 enrolled